Abstract
Dosage of serum AFP (alpha-fetoprotein) is widely used for HCC screening in patients with chronic liver disease. Virus-related chronic liver disease is the main cause of cirrhosis and HCC in Western and Far Eastern countries, but the relationship between viral etiology and AFP levels in HCC is still unclear. The aim of this study was to verify, in Western patients with post-viral chronic liver disease, the usefulness of AFP dosage for the detection of HCC, and the influence of viral etiology on AFP levels in HCC.
Lingua originale | English |
---|---|
pagine (da-a) | 1654-1658 |
Numero di pagine | 5 |
Rivista | Hepato-Gastroenterology |
Volume | 47 |
Stato di pubblicazione | Pubblicato - 2000 |
Keywords
- Biological Markers
- Carcinoma, Hepatocellular
- Chronic Disease
- Female
- Hepatitis B, Chronic
- Hepatitis C, Chronic
- Humans
- Italy
- Liver Diseases
- Liver Neoplasms
- Logistic Models
- Male
- Middle Aged
- Predictive Value of Tests
- Sensitivity and Specificity
- alpha-Fetoproteins